azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet

RxCUI: 1235144
RxNorm name: azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet
Display name: azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet
Full name: azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Edarbyclor	AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	e60f795b-fce3-4361-aa03-f143451689d1	2022-07-01	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1235144

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
e60f795b-fce3-4361-aa03-f143451689d1	azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet	PSN	18	These highlights do not include all the information needed to use EDARBYCLOR safely and effectively. See full prescribing information for EDARBYCLOR. EDARBYCLOR (azilsartan medoxomil and chlorthalidone) tablets, for oral use Initial U.S. Approval: 2011	20220701
e60f795b-fce3-4361-aa03-f143451689d1	azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet	SCD	18	These highlights do not include all the information needed to use EDARBYCLOR safely and effectively. See full prescribing information for EDARBYCLOR. EDARBYCLOR (azilsartan medoxomil and chlorthalidone) tablets, for oral use Initial U.S. Approval: 2011	20220701